These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 28167263

  • 1. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X, Han M, Xu J, Geng S, Zhang Y, Ye X, Gou J, Yin T, He H, Tang X.
    Int J Pharm; 2017 Mar 30; 520(1-2):98-110. PubMed ID: 28167263
    [Abstract] [Full Text] [Related]

  • 2. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
    Jiang Y, Liu X, Tan X, Hou Y, Sun W, Gou J, Yin T, He H, Zhang Y, Tang X.
    AAPS PharmSciTech; 2020 Oct 08; 21(7):277. PubMed ID: 33033942
    [Abstract] [Full Text] [Related]

  • 3. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
    Zhang H, Xiao Y, Cui S, Zhou Y, Zeng K, Yan M, Zhao C.
    J Nanosci Nanotechnol; 2015 Jun 08; 15(6):4058-69. PubMed ID: 26369013
    [Abstract] [Full Text] [Related]

  • 4. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    J Pharm Sci; 2005 Oct 08; 94(10):2266-75. PubMed ID: 16136555
    [Abstract] [Full Text] [Related]

  • 5. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo.
    Nie H, Qiu B, Yang QX, Zhao Y, Liu XM, Zhang YT, Liao FL, Zhang SY.
    J Liposome Res; 2021 Mar 08; 31(1):79-89. PubMed ID: 31691619
    [Abstract] [Full Text] [Related]

  • 6. Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.
    Zhou L, Zou M, Zhu K, Ning S, Xia X.
    Molecules; 2019 Aug 24; 24(17):. PubMed ID: 31450608
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO, Nagarsenker MS, Barhate CR, Padhye SG, Dhawan VV, Bhattacharyya D, Viswanathan CL, Steiniger F, Fahr A.
    Carbohydr Res; 2015 May 18; 408():33-43. PubMed ID: 25841057
    [Abstract] [Full Text] [Related]

  • 8. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
    Liu MC, Liu L, Wang XR, Shuai WP, Hu Y, Han M, Gao JQ.
    Int J Nanomedicine; 2016 May 18; 11():1395-412. PubMed ID: 27110110
    [Abstract] [Full Text] [Related]

  • 9. Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell-Targeting Effect.
    Ding R, Li Z, Wang J, Zhu X, Zhao Z, Wang M.
    J Pharm Sci; 2019 Sep 18; 108(9):3074-3081. PubMed ID: 30981753
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ, Kikkeri R, Maglinao M, Laurino P, Collot M, Hong SY, Lepenies B, Seeberger PH.
    Org Biomol Chem; 2010 Nov 07; 8(21):4987-96. PubMed ID: 20820666
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo.
    Xiao Y, Zhang H, Zhang Z, Yan M, Lei M, Zeng K, Zhao C.
    Int J Nanomedicine; 2013 Nov 07; 8():3033-50. PubMed ID: 23976853
    [Abstract] [Full Text] [Related]

  • 12. A novel hepatic-targeting system for therapeutic cytokines that delivers to the hepatic asialoglycoprotein receptor, but avoids receptor-mediated endocytosis.
    Sato H, Kato Y, Hayasi E, Tabata T, Suzuki M, Takahara Y, Sugiyama Y.
    Pharm Res; 2002 Nov 07; 19(11):1736-44. PubMed ID: 12458681
    [Abstract] [Full Text] [Related]

  • 13. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
    D'Souza AA, Devarajan PV.
    J Control Release; 2015 Apr 10; 203():126-39. PubMed ID: 25701309
    [Abstract] [Full Text] [Related]

  • 14. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
    Pathak P, Dhawan V, Magarkar A, Danne R, Govindarajan S, Ghosh S, Steiniger F, Chaudhari P, Gopal V, Bunker A, Róg T, Fahr A, Nagarsenker M.
    Int J Pharm; 2016 Jul 25; 509(1-2):149-158. PubMed ID: 27231122
    [Abstract] [Full Text] [Related]

  • 15. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
    Li T, Yu P, Chen Y, Sun B, Dong P, Zhu T, Meng X.
    Eur J Med Chem; 2021 Oct 15; 222():113605. PubMed ID: 34126457
    [Abstract] [Full Text] [Related]

  • 16. Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.
    Margarida Cardoso M, Peça IN, Raposo CD, Petrova KT, Teresa Barros M, Gardner R, Bicho A.
    J Microencapsul; 2016 Jun 15; 33(4):315-22. PubMed ID: 27189857
    [Abstract] [Full Text] [Related]

  • 17. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
    Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2000 Mar 15; 17(3):306-13. PubMed ID: 10801219
    [Abstract] [Full Text] [Related]

  • 18. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
    Korb V, Tep K, Escriou V, Richard C, Scherman D, Cynober L, Chaumeil J, Dumortier G.
    Crit Rev Ther Drug Carrier Syst; 2008 Mar 15; 25(4):305-45. PubMed ID: 18540841
    [Abstract] [Full Text] [Related]

  • 19. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S, Yamashita F, Nishikawa M, Takakura Y, Hashida M.
    Biochem Biophys Res Commun; 1998 Nov 09; 252(1):78-83. PubMed ID: 9813149
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
    Sakashita M, Mochizuki S, Sakurai K.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5212-9. PubMed ID: 25155912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.